SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
To compare the effects of formoterol alone (Oxis® TurbuhalerÒ) and the fixed combination of
formoterol and budesonide (Symbicort® TurbuhalerÒ) on airway responsiveness as a marker of
inflammation, induced by repeated low-dose allergen challenge in allergic patients with mild
asthma
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate